Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from William Blair

From In-N-Out to McDonald’s: The restaurant chains with the highest and lowest employee satisfaction scores revealed

91 percent of In-N-Out employees said they’d recommend their jobs to a friend

The Independent UK

Elon Musk’s ‘KILL the BILL’ Sends Tesla Shares Down. Is It Time to Sell TSLA Stock Here?

Elon Musk’s ‘KILL the BILL’ Sends Tesla Shares Down. Is It Time to Sell TSLA Stock Here?

Tesla shares crater as President Donald Trump says he’s disappointed in Elon Musk. A William Blair analyst remains bullish on TSLA stock.

Analysts Are Pounding the Table on This ‘Pioneer’ Nuclear Energy Stock

Analysts Are Pounding the Table on This ‘Pioneer’ Nuclear Energy Stock

This nuclear stock has received a positive analyst rating after a favorable announcement from the government.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Trump's 'Consequential' Shift In Energy Policy Fuels Upgrades For These Nuclear Stocks

President Donald Trump signed executive orders to support the nuclear industry last week.

Investors Business Daily

Tariff Uncertainty Hangs Over Amazon With Q1 Report Due Soon

Amazon stock rallied last week on hopes the Trump China tariffs will be reversed or lowered.

Investors Business Daily

DOGE's Loss Of Tesla's Elon Musk Could Be This Group's Gain

Elon Musk's departure from DOGE may brighten the outlook for military IT contractors such as Booz Allen Hamilton.

Investors Business Daily

This Analyst Is Calling for ‘Near Term’ Upside in Palantir Stock Despite the Tariffs Selloff

A William Blair analyst says Palantir stock is positioned for near-term gains. Should you buy the recent dip in PLTR shares then?

inkl

Read news from The Economist, FT, and more,
with one subscription

Palantir To Win U.S. Army Contract With L3Harris, Anduril, Says Analyst

Palantir To Win U.S. Army Contract With L3Harris, Anduril, Says Analyst

Palantir is poised to win a U.S. Army contract that could eventually deliver annual recurring revenue approaching $100 million, said a William Blair analyst.

Investors Business Daily

The Bloodshed in Palantir Stock Is So Bad This Analyst Just Upgraded the Stock

The Bloodshed in Palantir Stock Is So Bad This Analyst Just Upgraded the Stock

A continued rout in Palantir stock made one of its long-time skeptics change his stance on the big data analytics firm on Wednesday.

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

NeoGenomics stock jumped Wednesday after the company issued a strong 2025 outlook. That partially reversed a recent selloff.

Investors Business Daily

Affirm, SoFi Initiated At Outperform In Consumer Digital Financing

Affirm, SoFi Initiated At Outperform In Consumer Digital Financing

William Blair initiated coverage of Affirm stock and SoFi with outperform ratings viewing them as share gainers in the consumer financing market.

Investors Business Daily

Meta's Generative AI Push Could Bring Big 'Windfall' For WhatsApp, Analyst Says

Meta's Generative AI Push Could Bring Big 'Windfall' For WhatsApp, Analyst Says

A Meta stock analyst said the company's generative AI push could help drive new revenue from WhatsApp through chatbots.

Investors Business Daily

3 Tech Stocks to Buy for Steady Growth in 2025

3 Tech Stocks to Buy for Steady Growth in 2025

These companies all have huge growth potential in 2025 thanks to innovation and transformation in industries like data centers and artificial intelligence.

These Drone Stocks May Be On The Case In New Jersey

These Drone Stocks May Be On The Case In New Jersey

Drone stocks have gotten a tailwind from mysterious sightings over New Jersey. Axon and AeroVironment are among those who stand to benefit, William Blair said.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Regulatory Setback For Applied Therapeutics' Lead Program, FDA Highlights Deficiencies In Clinical Application

FDA rejected Applied Therapeutics' Govorestat for galactosemia, citing NDA deficiencies. The company plans discussions for resubmission or appeal.

Chipotle's new CEO gets approving nod from analysts

Boatwright is likely to look to new CFO Adam Rymer as a strategic partner.

Investors Business Daily

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024."

Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data

Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's what you need to know.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Royal Caribbean Clears Entry, Surges On Results, Hiked Guidance

Royal Caribbean stock surged to clear an add-on opportunity Tuesday after the cruise giant hiked its outlook with Q3 results.

1 AI Growth Stock to Grab While It's Under $100

This AI stock is currently trading below $100 following a pullback, which could be a perfect window for investors to snag this growth stock now.

Investors Business Daily

Stock Of The Day: SPX Technologies Rides Data Centers, Pharma-Led Growth To Big Gains

SPX Technologies is Stock Of The Day as the HVAC innovator capitalizes on growth opportunities serving data centers, drugmakers and more.

Investors Business Daily

Top Stocks For Q4: 6 Consumer, Housing And Infrastructure Stocks

Keep your eye on these six top stocks for Q4 in the consumer, infrastructure and housing sectors, including Steven Madden and Wolverine World Wide.

Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.

Is Tesla Stock a Buy for Energy Storage Upside?

This article explores whether Tesla stock is a good investment for those looking to capitalize on the potential growth of its energy storage business, which is increasingly seen as a significant driver of future upside.

Chewy Stock Soars on Big Profit Beat. Is It Time to Buy?

Chewy is red-hot Wednesday after the pet products retailer posted impressive Q2 earnings. Here's what Wall Street has to say about the stock.

People

119,835 stories

Scott Boatwright

Stéphane Bancel

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

277,080 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play